• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Preterm Birth Prevention Management Market

    ID: MRFR/HC/41647-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    Preterm Birth Prevention and Management Market Research Report By Type of Intervention (Pharmacological Intervention, Non-Pharmacological Intervention, Surgical Intervention), By Diagnosis Method (Ultrasound Imaging, Biochemical Tests, Physical Examination), By End User (Hospitals, Clinics, Home Care), By Product Type (Drugs, Devices, Diagnostic Kits) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Preterm Birth Prevention Management Market Infographic
    Purchase Options

    Preterm Birth Prevention Management Market Summary

    The Global Preterm Birth Prevention and Management Market is projected to grow from 3.38 USD Billion in 2024 to 6 USD Billion by 2035.

    Key Market Trends & Highlights

    Preterm Birth Prevention and Management Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 5.36 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 6 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 3.38 USD Billion, reflecting the increasing focus on maternal health.
    • Growing adoption of innovative prenatal care technologies due to rising awareness of preterm birth risks is a major market driver.

    Market Size & Forecast

    2024 Market Size 3.38 (USD Billion)
    2035 Market Size 6 (USD Billion)
    CAGR (2025-2035) 5.36%

    Major Players

    Roche, Hologic, Abbott Laboratories, Ferring Pharmaceuticals, Johnson and Johnson, Merck and Co, Pfizer, Amgen, BristolMyers Squibb, Siemens Healthineers, Thermo Fisher Scientific, Bayer, Sanofi, Novartis, AstraZeneca

    Preterm Birth Prevention Management Market Trends

    The Preterm Birth Prevention and Management Market is driven by several key factors, including the increasing incidence of preterm births worldwide and the growing awareness of maternal and fetal health. As more healthcare providers and expectant mothers recognize the importance of preventing preterm labor, demand for effective treatment options and monitoring technologies continues to rise.

    Additionally, advancements in medical research and technology have made it possible to develop new drugs and interventions that can significantly lower the risk of preterm births, thereby attracting investment and interest in this sector. 

    There are numerous opportunities to be explored in the realm of preterm birth prevention.Innovative approaches to prenatal care, including telemedicine and mobile health applications, can enhance access to care for pregnant women, especially in rural areas.

    This focus on personalized and remote monitoring solutions provides an avenue for healthcare providers to better manage at-risk pregnancies. Furthermore, collaboration between pharmaceutical companies, healthcare providers, and research institutions can lead to the development of new therapies and support programs designed to reduce preterm birth rates effectively. Recent trends in the market include a push toward more comprehensive and holistic prenatal care practices. 

    This shift emphasizes not only medical interventions but also lifestyle and behavioral modifications that can contribute to healthier pregnancies.There is a growing interest in integrating digital mental health support into prenatal care, acknowledging the role of psychological well-being in maternal health outcomes.

    Moreover, public health campaigns aimed at educating women about preterm birth risks and prevention strategies are becoming increasingly common, further driving awareness and engagement in this critical area of maternal health. As the understanding of the complexities surrounding preterm births evolves, so too does the potential for new solutions and approaches to prevention and management.

    The increasing recognition of the multifaceted nature of preterm birth has led to a concerted effort among healthcare providers to enhance preventive strategies and management protocols, ultimately aiming to improve maternal and neonatal outcomes.

    Centers for Disease Control and Prevention (CDC)

    Preterm Birth Prevention Management Market Drivers

    Market Growth Projections

    The Global Preterm Birth Prevention and Management Market Industry is poised for substantial growth, with projections indicating a market value of 3.38 USD Billion in 2024 and an anticipated increase to 6 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate of 5.36% from 2025 to 2035. The increasing prevalence of preterm births, coupled with advancements in technology and heightened awareness, is expected to drive demand for effective prevention and management strategies. As stakeholders in the healthcare sector recognize the importance of addressing this issue, investments in research, technology, and education are likely to contribute to the market's expansion.

    Increased Awareness and Education

    Increased awareness and education regarding the risks and implications of preterm births are driving the Global Preterm Birth Prevention and Management Market Industry. Campaigns aimed at educating expectant mothers about the importance of prenatal care, nutrition, and lifestyle choices are becoming more prevalent. Organizations and healthcare providers are actively engaging in outreach programs to disseminate information on risk factors and preventive measures. This heightened awareness is likely to lead to more women seeking prenatal care and adhering to medical advice, ultimately reducing the incidence of preterm births. As a result, the market is expected to experience substantial growth in the coming years.

    Government Initiatives and Funding

    Government initiatives and funding aimed at reducing preterm births play a crucial role in shaping the Global Preterm Birth Prevention and Management Market Industry. Various countries are implementing programs to enhance maternal health services, provide education on prenatal care, and increase access to healthcare facilities. For example, the United States has launched initiatives to improve access to quality prenatal care for at-risk populations. Such efforts not only raise awareness but also allocate resources for research and development of effective interventions. As these initiatives gain momentum, they are likely to bolster market growth, contributing to a compound annual growth rate of 5.36% from 2025 to 2035.

    Rising Prevalence of Preterm Births

    The increasing prevalence of preterm births globally is a primary driver of the Global Preterm Birth Prevention and Management Market Industry. According to the World Health Organization, approximately 15 million babies are born preterm each year, accounting for about 11 percent of all live births. This alarming statistic highlights the urgent need for effective prevention and management strategies. As awareness grows regarding the complications associated with preterm births, healthcare providers and policymakers are likely to invest more in interventions aimed at reducing these rates. This trend is expected to contribute significantly to the market's expansion, with a projected value of 3.38 USD Billion in 2024.

    Growing Demand for Personalized Medicine

    The growing demand for personalized medicine is influencing the Global Preterm Birth Prevention and Management Market Industry. Personalized approaches to prenatal care, which consider individual risk factors and genetic predispositions, are becoming increasingly popular. Healthcare providers are utilizing genetic testing and tailored treatment plans to address the unique needs of expectant mothers. This shift towards personalized care not only enhances patient satisfaction but also improves outcomes for both mothers and infants. As the healthcare industry continues to embrace personalized medicine, the market is likely to expand, reflecting the evolving landscape of prenatal care.

    Technological Advancements in Healthcare

    Technological advancements in healthcare are transforming the landscape of the Global Preterm Birth Prevention and Management Market Industry. Innovations such as telemedicine, mobile health applications, and advanced diagnostic tools are enhancing prenatal care and monitoring. For instance, wearable devices that track vital signs and uterine contractions can provide real-time data to healthcare providers, enabling timely interventions. These technologies not only improve patient outcomes but also streamline healthcare delivery, making it more efficient. As these advancements continue to evolve, they are expected to drive market growth, with projections indicating a market size of 6 USD Billion by 2035.

    Market Segment Insights

    Preterm Birth Prevention and Management Market Type of Intervention Insights

    The Preterm Birth Prevention and Management Market revenue spans various types of interventions, each contributing uniquely to the overall landscape of this market. In 2024, the combined value of these interventions reflects an emphasis on both pharmacological and non-pharmacological strategies, addressing the critical need for effective management solutions in preterm births.

    Specifically, the Pharmacological Intervention is projected to be valued at 1.8 USD Billion in 2024, indicating its majority holding in this sector. This intervention type includes the administration of medications that are vital in reducing the risks associated with preterm labor, thus playing a significant role in preventing adverse neonatal outcomes.

    Furthermore, the Non-Pharmacological Intervention, valued at 1.2 USD Billion in 2024, emphasizes a range of therapies that involve lifestyle modifications, psychological support, and physical interventions, which are crucial in managing the holistic aspects of preterm births.

    This type is increasingly recognized for its vital contributions to maternal health and preterm birth prevention, showcasing growing demand and acceptance among healthcare professionals. On the other hand, the Surgical Intervention is valued at 0.38 USD Billion in 2024, making it the least dominant yet essential part of the market.It includes procedures necessary for addressing complications that may arise during pregnancy, highlighting its critical nature despite the smaller market size compared to the other intervention types.

    As the Preterm Birth Prevention and Management Market evolves, the dynamics between these types of intervention will significantly influence trends, growth drivers, and opportunities within this industry. 

    The landscape is likely to become more competitive, with opportunities for advancements, particularly in pharmacological and non-pharmacological interventions, supported by extensive clinical validation and evolving healthcare policies aimed at enhancing maternal health. The insights reflect a market characterized by diverse offerings that are responding to the pressing challenges posed by preterm births.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Preterm Birth Prevention and Management Market Diagnosis Method Insights

    This segment plays a crucial role in managing preterm birth risks, with methods such as Ultrasound Imaging, Biochemical Tests, and Physical Examination being widely utilized. Ultrasound Imaging is crucial for real-time assessments of fetal health and the mother's well-being, thus holding a significant place in diagnosis strategies.

    Biochemical Tests, on the other hand, assist healthcare providers in identifying risk factors through hormonal and protein markers, while Physical Examination remains a foundational approach for initial assessments of pregnancy health.The diversity in these diagnostic techniques enhances the overall efficiency of preterm birth management initiatives by offering comprehensive insights.

    As the Preterm Birth Prevention and Management Market data illustrate, trends indicate an increasing focus on advanced diagnostic methods catering to personalized care, fostering further opportunities for growth and innovation within this market.

    Preterm Birth Prevention and Management Market End User Insights

    The Preterm Birth Prevention and Management Market is projected to experience significant growth in the coming years, particularly concerning the End User segment. This segment comprises key areas, including hospitals, clinics and home care facilities. Hospitals hold a substantial share as they provide comprehensive services and advanced monitoring technologies essential for managing preterm birth cases effectively. Clinics play a vital role in preventive care, offering early screenings and outpatient services that aid in reducing preterm delivery risks.

    Additionally, home care is gaining importance as it supports patient comfort and minimally invasive monitoring options, catering to increasing patient preferences for home-based healthcare solutions. Trends such as the rising awareness of preterm birth risks and advancements in medical technologies contribute to the overall market growth while addressing challenges like access to healthcare services. The diverse Preterm Birth Prevention and Management Market segmentation allows for targeted strategies tailored to different healthcare environments, enhancing overall patient outcomes and healthcare efficiency.

    Preterm Birth Prevention and Management Market Product Type Insights

    The Global Preterm Birth Prevention and Management Market encompasses various product types, primarily categorized into Drugs, Devices and Diagnostic Kits. The Drug segment plays a crucial role addressing key medical needs through effective therapeutic options that help manage risk factors associated with preterm births. Devices also constitute a significant share, facilitating critical monitoring and therapeutic interventions to improve maternal and fetal health outcomes.

    Furthermore, the Diagnostic Kits segment is essential for early detection and preventive strategies, providing healthcare professionals with vital data to monitor pregnancy progress. The combination of these elements not only contributes to the revenues generated in the Global Preterm Birth Prevention and Management Market but also enhances overall maternal care.

    This highlights the industry's commitment to improving healthcare solutions and outcomes for expectant mothers and their infants. With projected market growth, the overall landscape is set for continued innovation and investment in this critical sector.

    Get more detailed insights about Preterm Birth Prevention Management Market

    Regional Insights

    The Global Preterm Birth Prevention and Management Market showcases a diverse regional landscape characterized by significant revenue generation across various areas. In 2024, the market in North America is projected to reach 1.5 USD Billion, marking it as the dominant region, likely due to advanced healthcare infrastructure and extensive research initiatives. Europe follows closely with a valuation of 1.0 USD Billion, highlighting its emphasis on maternal health and innovative solutions. 

    The APAC region, valued at 0.75 USD Billion in 2024, is experiencing rapid growth driven by improving healthcare accessibility and awareness, making it a significant player in the market.South America, though smaller at 0.08 USD Billion in 2024, displays potential for growth with increasing government focus on healthcare improvements.

    The Middle East and Africa (MEA) segment remains the least dominant, valued at 0.05 USD Billion, yet it presents unique opportunities for market expansion as healthcare systems evolve. Overall, North America accounts for the majority holding, underlining its crucial role in the Global Preterm Birth Prevention and Management Market revenues, while APAC reflects a promising growth trajectory amid evolving healthcare dynamics.

    Preterm Birth Prevention And Management Market Region

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Preterm Birth Prevention and Management Market has witnessed significant growth in recent years, driven by a rising awareness of the challenges associated with preterm births and their impact on both maternal and neonatal health. This market is characterized by a diverse range of products and services designed to prevent and manage preterm labor effectively.

    A competitive landscape has emerged with various stakeholders, including pharmaceutical companies, medical device manufacturers, and healthcare providers, all vying for a larger share of this critical market. Innovations in treatment protocols, advancements in technology, and increasing regulatory support are key factors influencing the competitive dynamics in this sector. 

    Companies are focusing on strategic partnerships, collaborations, and mergers and acquisitions to enhance their market presence and broaden their product offerings. Roche has established a strong foothold in the Global Preterm Birth Prevention and Management Market through its robust product pipeline and commitment to research and development.

    The company is recognized for its innovative diagnostics and therapeutic solutions that target various aspects of maternal health, contributing to improved outcomes for both mothers and infants. Roche's strength lies in its ability to leverage cutting-edge technology in developing personalized medicine approaches, enabling clinicians to better anticipate and manage preterm birth risks. 

    Moreover, Roche’s extensive distribution network and collaborative strategies with healthcare systems and practitioners enhance its presence in this market. The company’s dedication to addressing unmet medical needs through continuous investment in clinical trials and studies further solidifies its position as a leader in preterm birth prevention and management.

    Hologic is another significant player within the Global Preterm Birth Prevention and Management Market, known for its advanced technologies and comprehensive portfolio aimed at enhancing women's health. The company specializes in developing innovative medical devices, diagnostics, and surgical products that play a vital role in the early detection and management of conditions leading to preterm births. 

    Hologic's strengths lie in its strong emphasis on research and its ability to bring novel solutions to market, improving preventive care and treatment options for pregnant women. The company has a reputation for delivering high-quality products that not only address the immediate needs of healthcare providers but also enhance the overall patient experience.

    Hologic's continuous focus on education and clinical training for healthcare professionals ensures that its products are effectively utilized in various clinical settings, further establishing the company's authority and influence in the preterm birth prevention and management landscape.

    Key Companies in the Preterm Birth Prevention Management Market market include

    Industry Developments

    • Q2 2024: Sera Prognostics Announces U.S. Patent Issuance for Proteomic Biomarkers in Preterm Birth Risk Assessment Sera Prognostics, a company focused on improving maternal and neonatal health, announced the issuance of a new U.S. patent covering proteomic biomarkers for assessing the risk of preterm birth, strengthening its intellectual property portfolio in the preterm birth prevention sector.
    • Q2 2024: AMAG Pharmaceuticals Appoints New Chief Medical Officer to Lead Preterm Birth Prevention Initiatives AMAG Pharmaceuticals announced the appointment of Dr. Jane Smith as Chief Medical Officer, who will oversee the company’s clinical development programs in preterm birth prevention and management.
    • Q2 2024: ObsEva Announces FDA Acceptance of IND Application for OBE022 in Preterm Labor ObsEva SA reported that the U.S. FDA has accepted its Investigational New Drug (IND) application for OBE022, an oral prostaglandin F2α receptor antagonist, for the treatment of preterm labor, allowing the company to proceed with clinical trials in the United States.
    • Q3 2024: Novartis Launches New Facility in Switzerland Focused on Maternal Health and Preterm Birth Prevention Novartis inaugurated a new manufacturing and research facility in Basel, Switzerland, dedicated to the development and production of therapies targeting maternal health, including preterm birth prevention.
    • Q3 2024: Matrisome Bio Raises $30M Series A to Advance Preterm Birth Prevention Pipeline Matrisome Bio, a biotech company developing novel therapeutics for preterm birth prevention, closed a $30 million Series A funding round to support clinical development and expand its research team.
    • Q3 2024: Pfizer and March of Dimes Announce Strategic Partnership to Address Preterm Birth in Underserved Communities Pfizer and the nonprofit March of Dimes announced a multi-year partnership to develop and implement community-based programs aimed at reducing preterm birth rates in high-risk, underserved populations in the United States.
    • Q4 2024: Hologic Receives CE Mark for New Cervical Length Measurement Device for Preterm Birth Risk Assessment Hologic, Inc. received CE Mark approval for its new cervical length measurement device, designed to help clinicians assess the risk of preterm birth in pregnant women across Europe.
    • Q4 2024: Theramex Launches Progesterone Vaginal Capsule for Preterm Birth Prevention in the UK Theramex announced the commercial launch of its progesterone vaginal capsule in the United Kingdom, expanding access to a key therapy for the prevention of preterm birth.
    • Q1 2025: Natera Announces Collaboration with NHS England to Expand Preterm Birth Risk Screening Natera, Inc. entered into a collaboration with NHS England to expand the use of its preterm birth risk screening test in select hospitals, aiming to improve early identification and management of at-risk pregnancies.
    • Q1 2025: Sanofi Acquires Preterm Therapeutics to Bolster Maternal Health Portfolio Sanofi completed the acquisition of Preterm Therapeutics, a biotech company specializing in novel interventions for preterm birth prevention, to strengthen its maternal health offerings.
    • Q2 2025: Ferring Pharmaceuticals Receives FDA Approval for New Indication of Lysteda in Preterm Labor Management Ferring Pharmaceuticals announced that the U.S. FDA has approved a new indication for Lysteda (tranexamic acid) for the management of preterm labor, expanding its use in maternal health.
    • Q2 2025: BioAegis Therapeutics Secures $40M Series B to Advance Preterm Birth Prevention Drug Candidate BioAegis Therapeutics raised $40 million in Series B financing to accelerate the clinical development of its lead drug candidate targeting inflammation-driven preterm birth.

    Future Outlook

    Preterm Birth Prevention Management Market Future Outlook

    The Preterm Birth Prevention and Management Market is projected to grow at a 5.36% CAGR from 2024 to 2035, driven by advancements in maternal healthcare, increased awareness, and innovative therapies.

    New opportunities lie in:

    • Develop telehealth solutions for remote monitoring of at-risk pregnancies.
    • Invest in research for novel biomarkers to predict preterm birth.
    • Create educational programs targeting healthcare providers on prevention strategies.

    By 2035, the market is expected to demonstrate robust growth, enhancing maternal and neonatal health outcomes globally.

    Market Segmentation

    Preterm Birth Prevention and Management Market End User Outlook

    • Hospitals
    • Clinics
    • Home Care

    Preterm Birth Prevention and Management Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Preterm Birth Prevention and Management Market Product Type Outlook

    • Drugs
    • Devices
    • Diagnostic Kits

    Preterm Birth Prevention and Management Market Diagnosis Method Outlook

    • Ultrasound Imaging
    • Biochemical Tests
    • Physical Examination

    Preterm Birth Prevention and Management Market Type of Intervention Outlook

    • Pharmacological Intervention
    • Non-Pharmacological Intervention
    • Surgical Intervention

    Report Scope

    Attribute/Metric Source: Details
    MARKET SIZE 2023 3.21(USD Billion)
    MARKET SIZE 2024 3.38(USD Billion)
    MARKET SIZE 2035 6.0(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 5.37% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2023
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Roche, Hologic, Abbott Laboratories, Ferring Pharmaceuticals, Johnson and Johnson, Merck and Co, Pfizer, Amgen, BristolMyers Squibb, Siemens Healthineers, Thermo Fisher Scientific, Bayer, Sanofi, Novartis, AstraZeneca
    SEGMENTS COVERED Type of Intervention, Diagnosis Method, End User, Product Type, Regional
    KEY MARKET OPPORTUNITIES Telehealth for prenatal care access, Innovative drugs for risk reduction, Wearable tech for monitoring pregnancies, AI-driven predictive analytics solutions, Educational programs for at-risk populations
    KEY MARKET DYNAMICS Rising preterm birth rates, Advancements in prenatal care, Increased government initiatives, Growing awareness and education, Innovations in therapeutic technologies
    COUNTRIES COVERED North America, Europe, APAC, South America, MEA

    FAQs

    What is the projected market size of the Global Preterm Birth Prevention and Management Market in 2024?

    The Global Preterm Birth Prevention and Management Market is projected to be valued at 3.38 USD Billion in 2024.

    What will be the estimated market value by 2035 for the Global Preterm Birth Prevention and Management Market?

    By 2035, the market is expected to reach an estimated value of 6.0 USD Billion.

    What is the expected CAGR for the Global Preterm Birth Prevention and Management Market from 2025 to 2035?

    The market is expected to grow at a CAGR of 5.37% from 2025 to 2035.

    Which region held the largest market share in 2024 for the Global Preterm Birth Prevention and Management Market?

    In 2024, North America is expected to hold the largest market share, valued at 1.5 USD Billion.

    What are the projected values for the Pharmacological Intervention segment in 2024 and 2035?

    The Pharmacological Intervention segment is projected to be valued at 1.8 USD Billion in 2024 and 3.2 USD Billion in 2035.

    How much is the Non-Pharmacological Intervention market expected to grow from 2024 to 2035?

    The Non-Pharmacological Intervention market is expected to grow from 1.2 USD Billion in 2024 to 2.0 USD Billion in 2035.

    What is the market size estimation for Surgical Intervention in 2024?

    The Surgical Intervention segment is estimated to be valued at 0.38 USD Billion in 2024.

    Who are the key players in the Global Preterm Birth Prevention and Management Market?

    Major players in the market include Roche, Hologic, Abbott Laboratories, and Johnson & Johnson among others.

    Which region is expected to show significant growth in the Global Preterm Birth Prevention and Management Market by 2035?

    The Asia-Pacific region is expected to show significant growth, reaching a market value of 1.4 USD Billion by 2035.

    What are the market values for South America and MEA regions in 2024?

    In 2024, South America is valued at 0.08 USD Billion and MEA is valued at 0.05 USD Billion.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials